Irwindeep Sandhu

Area of Study / Keywords

multiple myeloma leukemia Chimeric antigen receptor therapy cell therapy

---

About

Personal Statement:

Therapies for blood cancers like acute leukemia, lymphoma and multiple myeloma can have damaging effects on the heart and other organs. My work is focused on ensuring discoveries in research are validated and applied to patient care as quickly as possible. Working in collaboration with other health professionals, my goal is to see that each patient has the specific treatment needed to have the best possible outcome. 

After graduating from the University of Alberta’s medical school, Dr. Irwindeep Sandhu completed an internal medicine residency at the University of British Columbia and a hematology residency at McMaster University. He was recruited to the University of Alberta in 2009, where in addition to his position in the Division of Hematology, he has an adjunct appointment in the Department of Oncology.

Leadership and Collaborations: 

Dr. Sandhu is acting lead for the Northern Alberta Blood and Marrow Program and the medical director for the cellular apheresis program. He is a fellow in the Alberta Chapter of the American College of Physicians. He coordinates Hematologic care services for the Northwest Territories, and serves as inpatient teaching attending for the malignant hematology service at the Cross Cancer Institute.

Clinical Interests

Dr. Sandhu is a hematologist and oncologist who treats patients at the Cross Cancer Institute. He has a special interest in apheresis, leukemia, multiple myeloma and plasma cell dyscrasias, and cellular therapy. In 2016, he received a Champion of Care Award from a nomination by patient groups.

---

Research

Dr. Sandhu conducts translational research through collaborations with his colleagues and administers clinical trials in blood diseases such as acute leukemia and multiple myeloma. His findings have been published in several leading scientific journals including the New England Journal of Medicine, Haematologica, Blood, and Leukemia. His clinical and research contributions have helped develop the University of Alberta’s reputation as a leukemia centre and the Cross Cancer Institute’s strengths in multiple myeloma and cellular therapy. 

---

Teaching

Dr. Sandhu provides learning sessions for patients, family members and health care professionals on all hematology topics that include leukemia, clinical trials and multiple myeloma. He has taught, coordinated, and developed undergraduate, postgraduate and continuing medical education sessions. He has been awarded teaching awards for best ambulatory care experience and subspecialist of the year for the Department of Medicine.

BLOOD. 2022 August; https://doi.org/10.1182/blood.2022016293

---

Presented at 2022 International Myeloma Society Meeting. Los Angeles. Aug 25-27, 2022. 2022 August; DOI:10.1016/S2152-2650(22)00326-3

---

Lancet Haematology. 2022 June; 6 (9):403-414 https://doi.org/10.1016/S2352-3026(22)00103-X

---

Presented at European Hematology Association. Poster 942.. 2022 June;

---

British J of Haematology. April 2022; 197(s1): 119-120. British Society of Haematology Meeting. April 3-5, 2022.. 2022 April;

---

Presented Poster 14 European Myeloma Network Meeting. April 6-9, 2022.. 2022 April;

---

63rd American Society of Hematology Meeting, Atlanta, Georgia. December 11-14, 2021. Blood. . 2021 November;

---

63rd American Society of Hematology Meeting, Atlanta, Georgia. December 11-14, 2021 Blood. . 2021 November;

---

Lee A.S., Tsang R.Y., Sandhu I.

CMAJ. 2021 October; 193 (42):E1647-E1648 10.1503/CMAJ.202824-F

---

Lee A.S., Tsang R.Y., Sandhu I.

CMAJ. 2021 August; 193 (34):E1349 10.1503/cmaj.202824

---

Döhner H., Symeonidis A., Deeren D., Demeter J., Sanz M.A., Anagnostopoulos A., Esteve J., Fiedler W., Porkka K., Kim H.J., Lee J.H., Usuki K., D'Ardia S., Won Jung C., Salamero O., Horst H.A., Recher C., Rousselot P., Sandhu I., Theunissen K., Thol F., Döhner K., Teleanu V., Deangelo D.J., Naoe T., Sekeres M.A., Belsack V., Ge M., Taube T., Ottmann O.G.

HemaSphere. 2021 August; 5 (8):e617 10.1097/HS9.0000000000000617

---

Richardson P.G., Kumar S.K., Masszi T., Grzasko N., Bahlis N.J., Hansson M., Pour L., Sandhu I., Ganly P., Baker B.W., Jackson S.R., Stoppa A.M., Gimsing P., Garderet L., Touzeau C., Buadi F.K., Laubach J.P., Cavo M., Darif M., Labotka R., Berg D., Moreau P.

JOURNAL OF CLINICAL ONCOLOGY. 2021 August; 39 (22):2430-2442 10.1200/JCO.21.00972

---

Huang Y.H., Almowaled M., Li J., Venner C., Sandhu I., Peters A., Lavasanifar A., Lai R.

CURRENT ISSUES IN MOLECULAR BIOLOGY. 2021 June; 43 (1):313-323 10.3390/cimb43010026

---

Fenna, J., Guirguis, M., Ibrahim, C., Shirvaikar, N., Sandhu, I., Ghosh, S., Jenkins, M.

The Canadian Journal of Hospital Pharmacy. 2021 May; 74 (2):122-129. doi: 10.5737/23688076262137144.

---

Venner C.P., LeBlanc R., Sandhu I., White D., Belch A.R., Reece D.E., Chen C., Dolan S., Lalancette M., Louzada M., Kew A., McCurdy A., Monteith B., Reiman T., McDonald G., Sherry M., Gul E., Chen B.E., Hay A.E.

AMERICAN JOURNAL OF HEMATOLOGY. 2021 May; 96 (5):552-560 10.1002/ajh.26147

---

Virtual Conference 2021 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. 8 February, 2021.. 2021 February; https://doi.org/10.1016/S2666-6367(21)00483-8

---

Wei A.H., Döhner H., Pocock C., Montesinos P., Afanasyev B., Dombret H., Ravandi F., Sayar H., Jang J.H., Porkka K., Selleslag D., Sandhu I., Turgut M., Giai V., Ofran Y., Çakar M.K., de Sousa A.B., Rybka J., Frairia C., Borin L., Beltrami G., Cermák J., Ossenkoppele G.J., la Torre I., Skikne B., Kumar K., Dong Q., Beach C.L., Roboz G.J.

NEW ENGLAND JOURNAL OF MEDICINE. 2020 December; 383 (26):2526-2537 10.1056/NEJMoa2004444

---

Oncol Res Treat 2020;43(suppl 4): 38-38. Oral Presentation, abstract 296. 2020 October;